Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%
NDC 0404-0221, Chlorhexidine Gluconate, solution, from Henry Schein, Inc..
- Product NDC
- 0404-0221
- Status
- Listed
- Labeler
- Henry Schein, Inc.
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA019258
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0404-0221 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLORHEXIDINE GLUCONATE40 mg/mL
Pharmacologic classes
Decreased Cell Wall Integrity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0404-0221-04 | 00404022104 | 473 mL in 1 BOTTLE (0404-0221-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0404-0221 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0404-0221 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0404-0221. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.